| Date | Time | Room | Session Title | Presentation Time | Topic | Role |
|---|---|---|---|---|---|---|
| 2022-06-04 | 13:02 to 14:02 | BRAVS ROOM |
CLINICAL AND SURGICAL RETINA Lunch Symposium - LUNCH SYMPOSIUM ROCHE: BEYOND VEGF: TARGETING THE ANG–TIE PATHWAY FOR THE MANAGEMENT OF RETINAL DISEASES (28) |
13:13 to 13:20 | Role of Ang2 in retinal vascular diseases | Speaker |
| 2022-06-04 | 13:02 to 14:02 | BRAVS ROOM |
CLINICAL AND SURGICAL RETINA Lunch Symposium - LUNCH SYMPOSIUM ROCHE: BEYOND VEGF: TARGETING THE ANG–TIE PATHWAY FOR THE MANAGEMENT OF RETINAL DISEASES (28) |
13:27 to 13:45 | Discussion | Discussant |
| 2022-06-05 | 10:38 to 11:05 | BRAVS ROOM |
CLINICAL AND SURGICAL RETINA International Lecture - INTERNATIONAL LECTURES 07 (27) |
10:47 to 10:56 | Artificial Intelligence to Explore New Biomakers in AMD | Presenter |
| 2022-06-05 | 12:26 to 13:26 | BRAVS ROOM |
CLINICAL AND SURGICAL RETINA Lunch Symposium - LUNCH SYMPOSIUM ROCHE: LONGER-ACTING THERAPIES: OPTIMISING nAMD MANAGEMENT (59) |
12:44 to 12:54 | Phase 3 data | Speaker |
| 2022-06-05 | 12:26 to 13:26 | BRAVS ROOM |
CLINICAL AND SURGICAL RETINA Lunch Symposium - LUNCH SYMPOSIUM ROCHE: LONGER-ACTING THERAPIES: OPTIMISING nAMD MANAGEMENT (59) |
12:54 to 13:09 | Panel discussion | Discussant |